News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Rachel Capone, MSHS

Rachel Capone, MSHS

Rachel Capone, MSHS, is a regulatory affairs manager, Syner-G BioPharma Group.

Articles by Rachel Capone, MSHS

orphan drug / Pexels

Unlocking the Benefits of FDA’s Orphan Drug Designation

ByRachel Capone, MSHS

August 22nd 2023

Latest Updated Articles

Unlocking the Benefits of FDA’s Orphan Drug Designation
Published: August 22nd 2023 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Exploring Identity, Appearance Experiences Among Patients With Alopecia

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Real-World Evidence Backs Acalabrutinib in CLL Care

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text